BioCryst Pharmaceuticals | BCRX - Devedores Comerciais





Devedores Comerciais Alterar Data
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Chugai Pharma JPY 381.9B 28.96B 2026-06
Daiichi Sankyo JPY 676.92B 19.03B 2026-06
DBV Technologies USD 15.1M 1.05M 2026-03
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Glaxosmithkline GBP 10.49B 40.6M 2026-03
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novavax USD 106.45M 72.27M 2025-12
PTC Therapeutics USD 219.92M 38.3M 2026-03
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06